<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>121(12)</volume><submitter>Jesinghaus M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Cellular Dissociation Grade (CDG) composed of tumour budding and cell nest size has been shown to independently predict prognosis in pre-therapeutic biopsies and primary resections of oesophageal squamous cell carcinoma (ESCC). Here, we aimed to evaluate the prognostic impact of CDG in ESCC after neoadjuvant therapy.&lt;h4>Methods&lt;/h4>We evaluated cell nest size and tumour budding activity in 122 post-neoadjuvant ESCC resections, correlated the results with tumour regression groups and patient survival and compared the results with data from primary resected cases as well as pre-therapeutic biopsies.&lt;h4>Results&lt;/h4>CDG remained stable when results from pre-therapeutic biopsies and post-therapeutic resections from the same patient were compared. CDG was associated with thera</pubmed_abstract><journal>British journal of cancer</journal><pagination>1050-1057</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6964693</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma.</pubmed_title><pmcid>PMC6964693</pmcid><pubmed_authors>Feith M</pubmed_authors><pubmed_authors>Jesinghaus M</pubmed_authors><pubmed_authors>Boxberg M</pubmed_authors><pubmed_authors>Budczies J</pubmed_authors><pubmed_authors>Wilhelm D</pubmed_authors><pubmed_authors>Schlitter AM</pubmed_authors><pubmed_authors>Weichert W</pubmed_authors><pubmed_authors>Quante M</pubmed_authors><pubmed_authors>Konukiewitz B</pubmed_authors><pubmed_authors>Steiger K</pubmed_authors><pubmed_authors>Lange S</pubmed_authors><pubmed_authors>Dapper H</pubmed_authors><pubmed_authors>Friess H</pubmed_authors><pubmed_authors>Combs SE</pubmed_authors><pubmed_authors>Munch S</pubmed_authors><pubmed_authors>Mollenhauer M</pubmed_authors><pubmed_authors>Becker KF</pubmed_authors><pubmed_authors>Schlag C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma.</name><description>&lt;h4>Background&lt;/h4>Cellular Dissociation Grade (CDG) composed of tumour budding and cell nest size has been shown to independently predict prognosis in pre-therapeutic biopsies and primary resections of oesophageal squamous cell carcinoma (ESCC). Here, we aimed to evaluate the prognostic impact of CDG in ESCC after neoadjuvant therapy.&lt;h4>Methods&lt;/h4>We evaluated cell nest size and tumour budding activity in 122 post-neoadjuvant ESCC resections, correlated the results with tumour regression groups and patient survival and compared the results with data from primary resected cases as well as pre-therapeutic biopsies.&lt;h4>Results&lt;/h4>CDG remained stable when results from pre-therapeutic biopsies and post-therapeutic resections from the same patient were compared. CDG was associated with thera</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2025-05-18T11:51:51.332Z</modification><creation>2025-05-18T11:51:51.332Z</creation></dates><accession>S-EPMC6964693</accession><cross_references><pubmed>31690830</pubmed><doi>10.1038/s41416-019-0623-2</doi></cross_references></HashMap>